Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis
Shusuke Kumazaki(Osaka Gakuin University), Tetsuo Takehara(Osaka University), Yuta Myojin, Goki Suda(Hokkaido University), Hidenori Toyoda(Ogaki Municipal Hospital), Kazuhiro Murai(The University of Osaka), Yuki Tahata(The University of Osaka), Yutaka Sasaki(Iwate Medical University), Eiichi Morii(Osaka University of Economics), Yōichi Sasaki(Osaka Hospital), Kenji Fukumoto(The University of Osaka), Naruyasu Kakita(Takarazuka City Hospital), Takeshi Ebihara(The University of Osaka), Sadatsugu Sakane(The University of Osaka), Ji Hyun Sung, Tomohide Tatsumi(The University of Osaka), Kumiko Shirai(The University of Osaka), Takashi Kojima, Yoshinobu Saito, Hayato Hikita, Kentaro K. Shimizu(University of Zurich), Hirokazu Takahashi, Takahiro Kodama(Osaka University)
Institutional Repositories DataBase (IRDB)
June 3, 2024
Cited by 0
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
The wheat powdery mildew genome shows the unique evolution of an obligate biotroph
|Nature Genetics|2013|252
Sequencing of the genus Arabidopsis identifies a complex history of nonbifurcating speciation and abundant trans-specific polymorphism
|Nature Genetics|2016|222